Reference Values and Determinants of Hydration in Children 3-13 y
NCT ID: NCT02937038
Last Updated: 2021-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1454 participants
OBSERVATIONAL
2016-06-30
2021-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Develop reference values for hydration biomarkers for children of 3 to 13 years old
2. Explore the association between children's and parents' hydration markers and fluid intake habits in children aged 3-13 y
3. Evaluate the equivalence of spot urine osmolality to 24h urine osmolality in children aged 3-13 y
4. Evaluate the differences in hydration markers between school and non-school days in children aged 3-13 y
5. Examine the role of different foods and fluids on hydration in children (3-13 y) and parents
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DESHYDRAT : Assessment of the Prevalence of Dehydration Among 9 to 11 Year-old Children
NCT01268826
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
NCT01863381
Analysis of Longitudinal Cardiopulmonary Data
NCT00005221
Recognition of Abnormal Pediatric Blood Pressures in Primary Care
NCT00130663
A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
NCT06021860
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Kids 3-13 y
Healthy boys and girls of 3-13 y of age
No interventions assigned to this group
Parents 20-50 y
One of their Parents 20-50 y of age
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parent willing to participate as a subject as well
* Parents: aged 20-50
* Children and parents willing to collect urine samples and store them at room temperature
* Avoid strenuous exercise on day of collection
* Parent: included if \>50% of grocery shopping, food preparation, and feeding is handled by this parent
Exclusion Criteria
* Evidence of clinically relevant metabolic, cardiovascular, hematologic, hepatic, gastrointestinal, renal, pulmonary, endocrine or psychiatric history of disease, based on the medical history questionnaire
* Use of medication that interferes with water metabolism
* Surgical operation on digestive tract (e.g. bariatric surgery), except possible appendectomy
* Regular drug treatment within 15 days prior to start of the study
* Not willing to refrain from exercise on the day before and during urine collection
* Unwilling to collect urine
* Inability to participate in the entire study
* Pregnancy for females
Children:
* Use of Diapers
* Enuresis or use of nappies during the day or during the night
3 Years
13 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danone Global Research & Innovation Center
INDUSTRY
Arizona State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stavros Kavouras
Professor of Nutrition
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stavros A Kavouras, PhD
Role: PRINCIPAL_INVESTIGATOR
Arizona State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arizona State University
Phoenix, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-02-574
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.